CXCL10 and tuberculosis: The present data confirm that plasma IP-10 concentrations decrease significantly upon efficient TB therapy in both TB+HIV− and TB+HIV+ individuals and show that the rate of IP-10 down-regulation was lower in HIV co-infected subjects.